Spirit Scientific Co., Ltd. (TPEX:7790)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
52.40
+0.10 (0.19%)
At close: Jul 20, 2026
Market Cap973.84M -27.5%
Revenue (ttm)273.29M +20.7%
Net Income20.06M +297.0%
EPS1.08 +276.7%
Shares Out 18.58M
PE Ratio48.69
Forward PEn/a
Dividend0.57 (1.09%)
Ex-Dividend DateJul 13, 2026
Volume210
Open52.40
Previous Close52.30
Day's Range51.50 - 52.40
52-Week Range42.76 - 83.14
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateAug 17, 2026

About Spirit Scientific

Spirit Scientific Co., Ltd. engages in the production and sale of growth factor jelly-related products. The company offers Platelet Lyophilized Treatment (PLT), a high-concentration platelet therapy derived from autologous blood; PLT Hydraglow, a hydrogel lyophilization combined with a hyaluronic acid hydrating essence, serves as a post-treatment care system for damaged skin; PLTgel; and PLT-AE. It also provides lyophilized biomaterial testing and CDMO services; biomaterial-based raw material production services; and integrated packaging and de... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 2015
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 7790
Full Company Profile

Financial Performance

In 2025, Spirit Scientific's revenue was 273.29 million, an increase of 20.71% compared to the previous year's 226.39 million. Earnings were 20.06 million, an increase of 296.99%.

Financial Statements